Published in Osteoporos Int on April 01, 2014
QoL and Cognitive Function in Patients With Hypoparathyroidism (MR-hypoPT) | NCT04569604
PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy. J Clin Endocrinol Metab (2014) 0.93
Parathyroid hormone therapy for hypoparathyroidism. Best Pract Res Clin Endocrinol Metab (2014) 0.90
PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization. J Bone Miner Res (2015) 0.80
Management of Hypoparathyroidism: Present and Future. J Clin Endocrinol Metab (2016) 0.80
Hypoparathyroidism: Replacement Therapy with Parathyroid Hormone. Endocrinol Metab (Seoul) (2015) 0.79
Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway. J Clin Endocrinol Metab (2016) 0.77
Therapy of hypoparathyroidism by replacement with parathyroid hormone. Scientifica (Cairo) (2014) 0.77
PTH(1-84) replacement therapy for the treatment of hypoparathyroidism. Expert Rev Endocrinol Metab (2015) 0.75
Correlations Between Changes in Undercarboxylated Osteocalcin and Muscle Function in Hypoparathyroidism. Int J Endocrinol Metab (2016) 0.75
Review of Hypoparathyroidism. Front Endocrinol (Lausanne) (2017) 0.75
Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review. Endocrine (2017) 0.75
Impact of recombinant PTH on management of hypoparathyroidism: a systematic review. Eur Arch Otorhinolaryngol (2015) 0.75
The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc (1991) 31.17
Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys Ther (2002) 5.76
Simple method for measurement of lower extremity muscle strength. Am J Med (1985) 2.59
Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab (2003) 2.53
A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. J Clin Endocrinol Metab (1998) 1.73
Postural balance in a random sample of 7,979 subjects aged 30 years and over. Gerontology (2006) 1.61
Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study. J Bone Miner Res (2012) 1.54
Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. J Clin Endocrinol Metab (2011) 1.50
Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. J Clin Endocrinol Metab (2008) 1.46
The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone Miner Res (2011) 1.42
A rare case of idiopathic hypoparathyroidism with varied neurological manifestations. Intern Med (1996) 1.39
The diagnostic yield of quantified electromyography and quantified muscle biopsy in neuromuscular disorders. Muscle Nerve (1982) 1.39
Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol (2002) 1.35
Validation of the WHO-5 Well-Being Index in adolescents with type 1 diabetes. Diabetes Care (2007) 1.30
Analysis of electrical activity of normal muscle in man at different degrees of voluntary effort. J Neurol Neurosurg Psychiatry (1975) 1.23
The association between timed up and go test and history of falls: the Tromsø study. BMC Geriatr (2007) 1.23
Hypocalcaemic myopathy with paranoid psychosis. J Neurol Neurosurg Psychiatry (1976) 1.15
PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment. J Bone Miner Res (2013) 1.06
Receptors for the carboxyl-terminal region of pth(1-84) are highly expressed in osteocytic cells. Endocrinology (2001) 1.06
Idiopathic hypoparathyroidism with extrapyramidal and myopathic features. Arch Dis Child (1979) 0.98
The effect of PTH(1-84) on quality of life in hypoparathyroidism. J Clin Endocrinol Metab (2013) 0.96
The parathyroid hormone 2 (PTH2) receptor. Receptors Channels (2002) 0.96
Genetic and environmental effects on isometric muscle strength and leg extensor power followed up for three years among older female twins. J Appl Physiol (1985) (2009) 0.94
The psychiatric aspects of hypoparathyroidism. Acta Psychiatr Scand Suppl (1962) 0.94
Psychiatric aspects of parathyroid disease. Psychosomatics (2000) 0.92
Hypoparathyroidism and elevated muscle enzymes. Neurology (1980) 0.91
Hypoparathyroidism in a patient presenting with severe myopathy and skin rash. Case report and review of the literature. Hormones (Athens) (2006) 0.90
Hypocalcemic myopathy without tetany due to idiopathic hypoparathyroidism: case report. Arq Neuropsiquiatr (2004) 0.88
Abnormal muscle and hematopoietic gene expression may be important for clinical morbidity in primary hyperparathyroidism. Am J Physiol Endocrinol Metab (2007) 0.83
Maximal isometric knee extension strength and stair-mounting ability in 75- and 80-year-old men and women. Scand J Rehabil Med (1996) 0.82
Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors. Curr Pharm Des (2001) 0.82
The role of different EMG methods in evaluating myopathy. Clin Neurophysiol (2006) 0.82
Physical aspects of healthy aging: assessments of three measures of balance for studies in middle-aged and older adults. Curr Gerontol Geriatr Res (2011) 0.81
Depression as a manifestation of latent chronic hypoparathyroidism. World J Biol Psychiatry (2007) 0.80
High bone mass and hypocalcaemic myopathy in a patient with idiopathic hypoparathyroidism. Clin Rheumatol (2000) 0.79
Muscle histology of hypocalcaemic myopathy in hypoparathyroidism. J Neurol Neurosurg Psychiatry (1987) 0.78
Molecular cloning and functional characterization of the canine parathyroid hormone/parathyroid hormone related peptide receptor (PTH1). Mol Biol Rep (2001) 0.76
Turns analysis (peak ratio) in EMG using the mean amplitude as a substitute of force measurement. Electroencephalogr Clin Neurophysiol (1985) 0.75
Turns-amplitude analysis of the electromyographic recruitment pattern disregarding force measurement. II. Findings in patients with neuromuscular disorders. Muscle Nerve (1992) 0.75
Hypocalcemia, hypoparathyroidism, and organic anxiety syndrome. J Clin Psychiatry (1988) 0.75
[Neuropsychology of a psycho-organic syndrome caused by idiopathic hypoparathyroidism. Apropos of a case]. Encephale (1989) 0.75
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol (1999) 7.66
Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology (2001) 3.00
Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res (2001) 2.89
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int (2007) 2.46
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int (2006) 2.33
Vertebrate slow muscle fibers. Physiol Rev (1970) 2.31
Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis. Neurology (2011) 2.27
Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int (2005) 2.23
Fracture rates and risk factors for fractures in patients with spinal cord injury. Spinal Cord (1998) 2.07
The venous graft as an effector of early angiogenesis in a fibrin matrix. Microvasc Res (2007) 1.93
The sarcoplasmic reticulum, the T system, and the motor terminals of slow and twitch muscle fibers in the garter snake. J Cell Biol (1965) 1.89
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia (2005) 1.79
Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int (2008) 1.78
Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial. Eur J Neurol (2009) 1.73
Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science (1984) 1.72
Fracture risk associated with the use of morphine and opiates. J Intern Med (2006) 1.71
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res (1993) 1.57
Multisensory processing via early cortical stages: Connections of the primary auditory cortical field with other sensory systems. Neuroscience (2006) 1.53
Pain sensation and nociceptive reflex excitability in surgical patients and human volunteers. Br J Anaesth (1992) 1.52
Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) (1979) 1.49
Stereological considerations concerning the measurement of individual osteoid seams and resorption cavities. Bone Miner (1994) 1.47
Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ (2000) 1.47
Statins decrease bone turnover in postmenopausal women: a cross-sectional study. Eur J Clin Invest (2002) 1.46
Autosomal dominant osteopetrosis. Clin Orthop Relat Res (1993) 1.44
IFCN standards for digital recording of clinical EEG. International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol (1998) 1.43
Stroke in relation to use of raloxifene and other drugs against osteoporosis. Osteoporos Int (2010) 1.42
Familial isolated primary hyperparathyroidism. Clin Endocrinol (Oxf) (1994) 1.42
Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res Treat (2007) 1.41
A double-blind, controlled study of botulinum toxin A in chronic myofascial pain. Neurology (2006) 1.40
Polymorphisms of muscle genes are associated with bone mass and incident osteoporotic fractures in Caucasians. Calcif Tissue Int (2013) 1.40
Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein. Calcif Tissue Int (1989) 1.39
[Costs of different intervention strategies to prevent hip fractures]. Ugeskr Laeger (1999) 1.39
Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int (2006) 1.39
[Surgical treatment of epilepsy resistant to drug therapy. A review]. Ugeskr Laeger (1991) 1.38
Effect of training on corticomotor excitability in clinical neck pain. Eur J Pain (2014) 1.38
Developmental changes in the structure of the synapse on the myelinated cell bodies of the chicken ciliary ganglion. J Cell Biol (1965) 1.37
Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut (2000) 1.33
Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) (2005) 1.30
Assigning priority to patients requiring coronary revascularization: consensus principles from a panel of cardiologists and cardiac surgeons. Can J Cardiol (1991) 1.29
Vitamin D and its binding protein Gc: long-term variability in peri- and postmenopausal women with and without hormone replacement therapy. Scand J Clin Lab Invest (2006) 1.29
The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab (1988) 1.29
Fracture risk in patients treated for hyperthyroidism. Thyroid (2000) 1.25
Two cases of milk fever in cows after oestrus. Can Vet J (1969) 1.24
Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone (1990) 1.23
Analysis of electrical activity of normal muscle in man at different degrees of voluntary effort. J Neurol Neurosurg Psychiatry (1975) 1.23
Lumbar vertebral body compressive strength evaluated by dual-energy X-ray absorptiometry, quantitative computed tomography, and ashing. Bone (1999) 1.22
Human immunodeficiency virus induces phosphorylation of its cell surface receptor. Nature (1988) 1.20
Chemical, electron microscopic and physiological observations on the role of catecholamines in the carotid body. Brain Res (1969) 1.19
Age- and sex-related changes in iliac cortical bone mass and remodeling. Bone (1994) 1.19
Fractures in patients with primary idiopathic hypothyroidism. Thyroid (2000) 1.17
Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals. Bone (1987) 1.17
Normal vertebral body size and compressive strength: relations to age and to vertebral and iliac trabecular bone compressive strength. Bone (1986) 1.16
Histomorphometric analysis of normal bone from the iliac crest. Acta Pathol Microbiol Scand A (1978) 1.16
Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial. Eur J Intern Med (2013) 1.14
The occurrence, structure and innervation of slow and twitch muscle fibres in the tensor tympani and stapedius of the cat. J Physiol (1969) 1.14
Differences in internal structure and nerve terminals of the slow and twitch muscle fibers in the cat superior oblique. Anat Rec (1966) 1.14
Vitamin D insufficiency in Greenlanders on a westernized fare: ethnic differences in calcitropic hormones between Greenlanders and Danes. Calcif Tissue Int (2003) 1.14
Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition. Metab Bone Dis Relat Res (1984) 1.14
Fracture risk is increased in epilepsy. Acta Neurol Scand (1999) 1.13
Tetracycline double-labeling of iliac trabecular bone in 41 normal adults. Calcif Tissue Res (1978) 1.12
Cutaneomotor integration in humans is somatotopically organized at various levels of the nervous system and is task dependent. Exp Brain Res (2000) 1.12
Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int (1999) 1.12
Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study. J Neurol Neurosurg Psychiatry (2007) 1.11
Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone (1996) 1.11
The structure of vertebrate slow and twitch muscle fibers. Invest Ophthalmol (1967) 1.10
Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approach. Bone (1999) 1.10
Trabecular bone remodeling and balance in primary hyperparathyroidism. Bone (1986) 1.10
Sensory function in spinal cord injury patients with and without central pain. Brain (2003) 1.10
Effects of 25OHD concentrations on chances of pregnancy and pregnancy outcomes: a cohort study in healthy Danish women. Eur J Clin Nutr (2012) 1.09
Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int (2011) 1.08
Soluble CD163: a marker molecule for monocyte/macrophage activity in disease. Scand J Clin Lab Invest Suppl (2002) 1.08
Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner (1994) 1.07
A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone (1989) 1.06
Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int (2006) 1.06
Reduced relative risk of fractures among users of lithium. Calcif Tissue Int (2005) 1.05
Diagnostic yield of the analysis of the pattern of electrical activity of muscle and of individual motor unit potentials in neurogenic involvement. J Neurol Neurosurg Psychiatry (1977) 1.03
Correlation between transmission and structure in avian ciliary ganglion synapses. J Physiol (1969) 1.03
An evaluation of the quantitative parameters applied in bone histology. Acta Pathol Microbiol Scand A (1978) 1.02